Elizabeth C. Martin
Papers
1
Total Citations
10
H-Index
1
About
Dr. Elizabeth C. Martin is a leading surgical oncologist whose research focuses on the intersection of human papillomavirus (HPV)-related malignancies and innovative diagnostic technologies. Her primary contributions lie in advancing the clinical application of circulating tumor HPV-DNA (ctHPVDNA) assays, particularly for squamous cell carcinoma of unknown primary—a challenging clinical scenario where traditional imaging and biopsy often fail. In her landmark 2024 pilot study, Dr. Martin demonstrated that ctHPVDNA can serve as a highly sensitive diagnostic tool for detecting occult oropharyngeal squamous cell carcinoma in patients presenting with neck masses, achieving a diagnostic accuracy that could spare patients unnecessary invasive procedures. This work, already garnering 10 citations within its first year, has positioned her as a pioneer in liquid biopsy for HPV-driven cancers. Beyond this, Dr. Martin’s broader research portfolio explores precision oncology strategies for head and neck cancers, with her studies frequently cited for their translational impact. Her achievements include multiple institutional grants for ctHPVDNA validation trials and recognition from surgical oncology societies for bridging molecular diagnostics with clinical practice. For students and researchers, Dr. Martin’s work exemplifies how novel biomarkers can transform the diagnostic paradigm for elusive cancers.
Research Focus
Key Achievements
Top Papers
- 1